Related references
Note: Only part of the references are listed.Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study
Borge G. Nordestgaard et al.
PHARMACOGENETICS AND GENOMICS (2010)
Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study
Julie A. Johnson et al.
AMERICAN HEART JOURNAL (2009)
Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?
Donna K. Arnett et al.
CURRENT OPINION IN CARDIOLOGY (2009)
Blood pressure control and physicians' therapeutic behavior in a very elderly Spanish hypertensive population
Gustavo C. Rodriguez-Roca et al.
HYPERTENSION RESEARCH (2009)
Opportunities and Challenges for the NIH -- An Interview with Francis Collins.
Robert Steinbrook et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance
Donna K. Arnett et al.
PHARMACOGENOMICS (2009)
α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes:: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)
Tobias Gerhard et al.
AMERICAN HEART JOURNAL (2008)
beta 1- and beta 2-adrenergic receptor gene beta-blocker use and risk of myocardial infarction and stroke
Rozenn N. Lemaitre et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
M. A. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
Stephen T. Turner et al.
HYPERTENSION (2008)
Physiological interaction between α-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation
Paolo Manunta et al.
HYPERTENSION (2008)
The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade
A. Kelley-Hedgepeth et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
KCNMB1 genotype influences response to verapamil SIR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)
Amber L. Beitelshees et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pharmacogenetics of β-blockers
Jaekyu Shin et al.
PHARMACOTHERAPY (2007)
Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons:: the Genetics of Hypertension-Associated Treatment Study
B. R. Davis et al.
PHARMACOGENOMICS JOURNAL (2007)
Current status of antihypertensive prescription and associated blood pressure control in Japan
Hisao Mori et al.
HYPERTENSION RESEARCH (2006)
Pharmacogenetics of antihypertensive treatment
DK Arnett et al.
VASCULAR PHARMACOLOGY (2006)
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment - The genetics of hypertension-associated treatment (GenHAT) study
DK Arnett et al.
CIRCULATION (2005)
Global burden of hypertension: analysis of worldwide data
PM Kearney et al.
LANCET (2005)
The burden of adult hypertension in the United States 1999 to 2000 - A rising tide
LE Fields et al.
HYPERTENSION (2004)
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension
I Zineh et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Genome-wide mapping of human loci for essential hypertension
M Caulfield et al.
LANCET (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Diuretic therapy, the α-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension
BM Psaty et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Antihypertensive pharmacogenetics: getting the right drug into the right patient
ST Turner et al.
JOURNAL OF HYPERTENSION (2001)